Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.

[1]  Hans T. Chung,et al.  Accelerating prostate stereotactic ablative body radiotherapy: Efficacy and toxicity of a randomized phase II study of 11 versus 29 days overall treatment time (PATRIOT). , 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Anurag K. Singh,et al.  Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  L. Goldstein,et al.  Predicting Factors Associated with Postoperative Hypotension following Carotid Artery Stenting. , 2019, Annals of vascular surgery.

[4]  Shiva K. Das,et al.  Fitting NTCP models to SBRT dose and carotid blowout syndrome data , 2018, Medical physics.

[5]  J. Lewinger,et al.  Comparison of devices used in carotid artery stenting: A vascular quality initiative analysis of commonly used carotid stents and embolic protection devices , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  D. Heron,et al.  Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy. , 2017, International journal of radiation oncology, biology, physics.

[7]  J. Laird,et al.  Long-term outcomes after carotid artery stenting of patients with prior neck irradiation or surgery. , 2017, Cardiovascular revascularization medicine : including molecular interventions.

[8]  K. Himei,et al.  Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife® , 2017, Molecular and clinical oncology.

[9]  R. Orecchia,et al.  Risk of carotid blowout after reirradiation with particle therapy , 2017, Advances in radiation oncology.

[10]  D. Heron,et al.  A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer. , 2017, International journal of radiation oncology, biology, physics.

[11]  R. Yaparpalvi,et al.  Stereotactic body radiotherapy for recurrent head and neck cancer: A critical review , 2017, Head & neck.

[12]  D. Heron,et al.  Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers. , 2017, Future oncology.

[13]  H. Cloft,et al.  Endovascular treatment of carotid blowout syndrome , 2017, Journal of vascular surgery.

[14]  N. Manzoor,et al.  Contemporary management of carotid blowout syndrome utilizing endovascular techniques , 2017, The Laryngoscope.

[15]  X. Gu,et al.  Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning , 2016, Journal of applied clinical medical physics.

[16]  P. Xia,et al.  A feasibility Study of the Dosimetric Compliance Criteria of the NRG-HN002 Head and Neck Clinical Trial Across Different Radiotherapy Treatment Planning Systems and Delivery Techniques: A Model for Optimizing Initial Trial Launch , 2016 .

[17]  B. Wollenberg,et al.  Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases , 2016, European Archives of Oto-Rhino-Laryngology.

[18]  D. Heron,et al.  Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer. , 2016, International journal of radiation oncology, biology, physics.

[19]  D. Heron,et al.  Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer , 2016, Cancer journal.

[20]  X Allen Li,et al.  MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers , 2016, Physics in medicine and biology.

[21]  S. Asbell,et al.  Introduction and Clinical Overview of the DVH Risk Map. , 2016, Seminars in radiation oncology.

[22]  Ashish Patel,et al.  Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels. , 2016, Seminars in radiation oncology.

[23]  K. Himei,et al.  Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife , 2015, Radiation oncology.

[24]  R. Steenbakkers,et al.  CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  D. Yavagal,et al.  Covered Stents for the Prevention and Treatment of Carotid Blowout Syndrome. , 2015, Neurosurgery.

[26]  K. Himei,et al.  Carotid blowout syndrome in pharyngeal cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife: A multi-institutional matched-cohort analysis. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  D. Heron,et al.  A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck. , 2015, International journal of radiation oncology, biology, physics.

[28]  D. Heron,et al.  Examining tumor control and toxicity after stereotactic body radiotherapy in locally recurrent previously irradiated head and neck cancers: Implications of treatment duration and tumor volume , 2014, Head & neck.

[29]  E. Kunieda,et al.  Toxicities of Organs at Risk in the Mediastinal and Hilar Regions Following Stereotactic Body Radiotherapy for Centrally Located Lung Tumors , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[30]  D. Heron,et al.  Stereotactic Body Radiotherapy as Primary Treatment for Elderly Patients with Medically Inoperable Head and Neck Cancer , 2014, Front. Oncol..

[31]  D. Heron,et al.  Adjuvant stereotactic body radiotherapy ± cetuximab following salvage surgery in previously irradiated head and neck cancer , 2014, The Laryngoscope.

[32]  P. Bondiau,et al.  Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  P. Hurmuz,et al.  A simple strategy to decrease fatal carotid blowout syndrome after stereotactic body reirradiaton for recurrent head and neck cancers , 2013, Radiation oncology.

[34]  I. Poon,et al.  Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  K. Himei,et al.  Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  G A Whitfield,et al.  Interobserver variation in clinical target volume and organs at risk segmentation in post-parotidectomy radiotherapy: can segmentation protocols help? , 2012, The British journal of radiology.

[37]  H. Jang,et al.  Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment , 2012, Radiation oncology.

[38]  J. Flickinger,et al.  A retrospective, deformable registration analysis of the impact of PET-CT planning on patterns of failure in stereotactic body radiation therapy for recurrent head and neck cancer , 2012, Head & neck oncology.

[39]  P. Levendag,et al.  Stereotactic body radiotherapy: a promising treatment option for the boost of oropharyngeal cancers not suitable for brachytherapy: a single-institutional experience. , 2012, International journal of radiation oncology, biology, physics.

[40]  P. Johnstone,et al.  Risk of carotid blowout after reirradiation of the head and neck: a systematic review. , 2012, International journal of radiation oncology, biology, physics.

[41]  C. Hopper,et al.  Management of vascular complications of head and neck cancer. , 2012, The Journal of laryngology and otology.

[42]  F. Zorlu,et al.  Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. , 2011, International journal of radiation oncology, biology, physics.

[43]  D. Heron,et al.  The Impact of Tumor Volume and Radiotherapy Dose on Outcome in Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck Treated With Stereotactic Body Radiation Therapy , 2011, American journal of clinical oncology.

[44]  William Y. Song,et al.  A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy , 2011, Radiation oncology.

[45]  D. Heron,et al.  Concurrent Cetuximab With Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: A Single Institution Matched Case-Control Study , 2010, American journal of clinical oncology.

[46]  A. Noone,et al.  Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. , 2010, International journal of radiation oncology, biology, physics.

[47]  Joseph O Deasy,et al.  The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome. , 2010, International journal of radiation oncology, biology, physics.

[48]  E. Yorke,et al.  Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. , 2010, International journal of radiation oncology, biology, physics.

[49]  Fang-Fang Yin,et al.  Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. , 2009, International journal of radiation oncology, biology, physics.

[50]  Aswin L Hoffmann,et al.  Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.

[51]  D. Heron,et al.  Frameless Stereotactic Radiosurgery for Recurrent Head and Neck Carcinoma , 2006, Technology in cancer research & treatment.

[52]  Peter van Luijk,et al.  Unexpected changes of rat cervical spinal cord tolerance caused by inhomogeneous dose distributions. , 2003, International journal of radiation oncology, biology, physics.

[53]  J. Sham,et al.  Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. , 2003, International journal of radiation oncology, biology, physics.

[54]  C C Ling,et al.  Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. , 2001, International journal of radiation oncology, biology, physics.

[55]  C. Sasaki,et al.  Recurrent carotid blowout syndrome: diagnostic and therapeutic challenges in a newly recognized subgroup of patients. , 1999, AJNR. American journal of neuroradiology.

[56]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[57]  T E Schultheiss,et al.  Models in radiotherapy: volume effects. , 1983, Medical physics.

[58]  D. Heron,et al.  Dose-response modeling the risk of carotid bleeding events after stereotactic body radiation therapy for previously irradiated head and neck cancer. , 2019, Journal of radiosurgery and SBRT.

[59]  Clifton D Fuller,et al.  Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer. , 2016, Journal of applied clinical medical physics.

[60]  S. Koyfman,et al.  Carotid blowout in a patient with nasopharyngeal carcinoma treated with SBRT re-irradiation for local recurrence using twice weekly treatment. , 2015, Journal of radiosurgery and SBRT.

[61]  J. Flickinger,et al.  Target delineation in stereotactic body radiation therapy for recurrent head and neck cancer: a retrospective analysis of the impact of margins and automated PET-CT segmentation. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[62]  H. Yamazaki,et al.  Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. , 2011, Journal of radiation research.

[63]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[64]  G J Kutcher,et al.  Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. , 1995, International journal of radiation oncology, biology, physics.

[65]  R. Fisher,et al.  On the Mathematical Foundations of Theoretical Statistics , 1922 .